| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 3 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | United States | 2 | |
| #4 | Argentina | 1 | |
| #5 | Australia | 1 | |
| #6 | Canada | 1 | |
| #7 | China | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 | |
| #10 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Williams Taffy J | 7 |
| #2 | Krell Robert D | 6 |
| #3 | Jacob Leonard S | 6 |
| #4 | Rose Martin | 3 |
| #5 | Tuszynski George | 3 |
| #6 | Do Ngoc | 2 |
| #7 | Actor Paul | 2 |
| #8 | Williams Taffy | 2 |
| #9 | Skiendzielewski Stephen | 2 |
| #10 | George Tuszynski | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2006118562A1 | Purgative composition and uses thereof | |
| MXPA01001885A | Angiocidin: a cysservalthrcysgly specific tumor cell adhesion receptor. | |
| US6380161B1 | Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions | |
| US6339062B1 | Retroinverso polypeptides that mimic or inhibit thrombospondin activity | |
| AU6591398A | Non-aqueous colonic purgative formulations |